Bovine Pericardial Valve Global Market Report 2026

A bovine pericardial valve is a bioprosthetic cardiac valve constructed from cow (bovine) pericardial tissue, utilized in heart surgeries to replace damaged or diseased natural valves. It provides high biocompatibility, enhanced blood flow performance, and durability, while being designed to minimize calcification and structural deterioration for improved long-term clinical outcomes.

The primary product types of bovine pericardial valve include surgical valves and transcatheter valves. Surgical valves refer to biologic heart valve replacements derived from bovine pericardial tissue, utilized in open-heart procedures to restore normal cardiac blood flow. The different age groups include pediatric and adult. The various applications involved are aortic valve replacement, mitral valve replacement, and tricuspid valve replacement, and they are used by several end users such as hospitals, cardiac centers, and ambulatory surgical centers.

Tariffs are influencing the bovine pericardial valve market by increasing the cost of imported biomaterials, surgical instruments, and specialized manufacturing components required for valve production and implantation procedures. This is elevating overall procedure expenses and restricting accessibility in price-sensitive regions, particularly in Asia-Pacific and Latin America where dependence on imported cardiac devices remains high. Segments such as surgical valves, transcatheter valves, and hospitals are most affected because of their reliance on global supply chains and regulated medical imports. However, tariffs are also encouraging domestic production of bioprosthetic valves, reinforcing regional manufacturing capabilities, and accelerating investments in local cardiac device innovation ecosystems.

The bovine pericardial valve market research report is one of a series of new reports from The Business Research Company that provides bovine pericardial valve market statistics, including bovine pericardial valve industry global market size, regional shares, competitors with a bovine pericardial valve market share, detailed bovine pericardial valve market segments, market trends and opportunities, and any further data you may need to thrive in the bovine pericardial valve industry. This bovine pericardial valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bovine pericardial valve market size has grown strongly in recent years. It will grow from $1.57 billion in 2025 to $1.72 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of valvular heart diseases in aging population, increasing adoption of open heart surgical valve replacement procedures, advancements in cardiac surgery techniques and perioperative care, growing availability of bioprosthetic valve options in hospitals, increasing awareness of cardiovascular disease treatment options.

The bovine pericardial valve market size is expected to see rapid growth in the next few years. It will grow to $2.53 billion by 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for minimally invasive and transcatheter procedures, rising global geriatric population driving valve replacement needs, advancement in tissue engineering and biomaterial innovation, growing preference for durable and low anticoagulation valve solutions, expanding healthcare infrastructure and cardiac care accessibility in emerging markets. Major trends in the forecast period include increasing adoption of advanced bioprosthetic heart valve materials with enhanced durability, rising demand for minimally invasive valve replacement procedures, growing focus on anti calcification treatment technologies in tissue valves, expansion of transcatheter heart valve implantation procedures, increasing clinical preference for long lasting biologic valve substitutes over mechanical valves.

The rising prevalence of cardiovascular diseases is expected to propel the growth of the bovine pericardial valve market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including coronary artery disease, ischemic heart disease, heart failure, and valvular conditions, and remain the leading cause of global morbidity and mortality. The increasing prevalence of cardiovascular diseases is primarily contributing to market expansion due to rising sedentary lifestyles. Reduced physical activity slows metabolic processes and encourages obesity, which significantly elevates the risk of heart-related disorders. The bovine pericardial valve supports cardiovascular diseases by providing a durable and highly biocompatible option for surgical valve replacement in patients suffering from CVDs, particularly in valvular heart disease cases that require long-term performance and a reduced likelihood of reoperation. For instance, in September 2025, according to the American College of Cardiology, a US-based medical association, cardiovascular disease deaths worldwide increased to 19.2 million in 2023, up from 2022. Therefore, the rising prevalence of cardiovascular diseases is contributing and propelling the growth of the bovine pericardial valve market.

The increasing preference for minimally invasive procedures is expected to propel the growth of the bovine pericardial valve market going forward. Minimally invasive procedures are medical interventions designed to minimize bodily trauma by utilizing small incisions or natural body openings, resulting in reduced pain, lower complication risks, and faster recovery compared to conventional open surgeries. The growing preference for minimally invasive procedures is largely supported by technological advancements in surgical instruments and techniques, which have enabled clinicians to perform complex cardiac interventions with greater precision and significantly improved patient recovery outcomes. The rising adoption of minimally invasive approaches is further contributing to increased utilization of bovine pericardial valves, as these tissue-based valves are well-suited for delivery through catheter-based and other minimally invasive cardiac surgical platforms. For instance, in June 2024, according to the American Society of Plastic Surgeons (ASPS), a US-based professional medical organization, more than 11,000 board-certified plastic surgeons worldwide reported that minimally invasive procedures grew by 7% in 2023 compared to 2022, with nearly 25.4 million such procedures performed in the United States in 2023, up from approximately 23.7 million in 2022. Therefore, the increasing preference for minimally invasive procedures is contributing and propelling the growth of the bovine pericardial valve market.

Leading companies operating in the bovine pericardial valve market are focusing on developing advanced products, such as next-generation surgical aortic tissue valves, to enhance procedural efficiency and long-term patient outcomes. A next-generation surgical aortic tissue valve is an advanced bioprosthetic valve designed to replace a diseased aortic valve with improved durability and performance. It enhances blood flow efficiency and reduces complications, supporting better patient outcomes. For example, in April 2024, Medtronic, an Ireland-based medical technology company, launched the Avalus Ultra Valve, a next-generation surgical aortic tissue valve designed to enhance ease of use during implantation and support lifetime patient management. The Avalus Ultra Valve features advanced tissue treatment for improved durability, optimized leaflet design for enhanced hemodynamic performance, and user-friendly handling characteristics that simplify surgical procedures, contributing to consistent clinical outcomes and long-term valve reliability.

Major companies operating in the bovine pericardial valve market are Shanghai Cingular Biotechnology Co Ltd, Medtronic plc, Edwards Lifesciences Corporation, Meril Life Sciences Pvt Ltd, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Braile Biomedica Industria Comercio e Representacoes SA, Venus Medtech Hangzhou Inc, Peijia Medical Limited, Artivion Inc, Balance Medical Limited, HighLife SAS, Maverick Biosciences Inc

North America was the largest region in the bovine pericardial valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bovine pericardial valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bovine pericardial valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bovine pericardial valve market consists of sales of bioprosthetic heart valve leaflets, pericardial tissue patches, cardiac repair membranes, and valve reconstruction grafts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bovine Pericardial Valve Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses bovine pericardial valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bovine pericardial valve ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bovine pericardial valve market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Surgical Valves; Transcatheter Valves
• 2) By Age Group: Pediatric; Adult
• 3) By Application: Aortic Valve Replacement; Mitral Valve Replacement; Tricuspid Valve Replacement
• 4) By End User: Hospitals; Cardiac Centers; Ambulatory Surgical Centers
• Subsegments:
• 1) By Surgical Valves: Aortic Valve; Mitral Valve; Tricuspid Valve; Pulmonary Valve
• 2) By Transcatheter Valves: Transcatheter Aortic Valve; Transcatheter Mitral Valve; Transcatheter Pulmonary Valve; Transcatheter Tricuspid Valve
• Companies Mentioned: Shanghai Cingular Biotechnology Co Ltd; Medtronic plc; Edwards Lifesciences Corporation; Meril Life Sciences Pvt Ltd; Lepu Medical Technology Beijing Co Ltd; MicroPort Scientific Corporation; Braile Biomedica Industria Comercio e Representacoes SA; Venus Medtech Hangzhou Inc; Peijia Medical Limited; Artivion Inc; Balance Medical Limited; HighLife SAS; Maverick Biosciences Inc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.